Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer.

European journal of pharmacology - 5 May 2015

Haghgoo Seyyed Mortaza, Allameh Abdolamir, Mortaz Esmaeil, Garssen Johan, Folkerts Gert, Barnes Peter J, Adcock Ian M

Abstract excerpt

Recent studies have been established high degree of genetic diversity in solid organ tumors among individuals and even between individual tumor cells. This intratumor and intertumor genetic diversity results in a heterogeneous tumor with unique characteristics which potentially allows effective drug therapy. The goal of pharmacogenomics is to elucidate the genetic network(s) that underlie drug efficacy and drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Lung Neoplasms

Share to Models, Biological

Share to Molecular Targeted Therapy

Share to Neoplastic Stem Cells

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 25725115
DOI: 10.1016/j.ejphar.2015.02.029

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer.PMID 25725115Read ↗

Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel PerspectiveSemantic proximity Read ↗

Targeted Therapy for Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond.Semantic proximity Read ↗

The Genomics of Lung Adenocarcinoma: Opportunities for Targeted TherapiesSemantic proximity Read ↗

Recent advances in lung cancer genomics: Application in targeted therapy.Semantic proximity Read ↗

Lung cancer genetics and pharmacogenomics.Semantic proximity Read ↗

Emerging application of genomics-guided therapeutics in personalized lung cancer treatmentSemantic proximity Read ↗

[Molecular profiling of non-small cell lung cancer].Semantic proximity Read ↗

The Impact of Genomic Profiling for Novel Cancer Therapy--Recent Progress in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.Semantic proximity Read ↗

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem CellsSemantic proximity Read ↗

Recent Advances in Personalized Lung Cancer MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.